CIK 0001516551
- Non-accelerated filer
- Smaller reporting company
Skye Bioscience, Inc.
Sign in to watch- Ticker
- SKYE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 450692882
- Phone
- +1 858-410-0266
- Business address
- 11250 EL CAMINO REAL, SUITE 100, SAN DIEGO, CA, 92130
- Former names
- Emerald Bioscience, Inc., Nemus Bioscience, Inc., LOAD GUARD LOGISTICS, INC., LOAD GUARD TRANSPORTATION, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $613,506
- in 6 filings
Net −$613,506. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-28 | Jenkins Annalisa Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2024-09-13 | Schwab Andrew J. Director | Sale | −11,758 | $6.06 | $71K | 8,167,206 |
| 2024-09-13 | Schwab Andrew J. Director | Sale | −2,000 | $6.06 | $12K | 1,679,685 |
| 2024-09-13 | Schwab Andrew J. Director | Sale | −79 | $6.06 | $479 | 66,277 |
| 2024-09-13 | 5AM Partners VII, LLC 10% owner | Sale | −11,758 | $6.06 | $71K | 8,167,206 |
| 2024-09-13 | 5AM Partners VII, LLC 10% owner | Sale | −2,000 | $6.06 | $12K | 1,679,685 |
| 2024-09-13 | 5AM Partners VII, LLC 10% owner | Sale | −79 | $6.06 | $479 | 66,277 |
| 2024-09-11 | Schwab Andrew J. Director | Sale | −214,556 | $6.60 | $1.4M | 8,178,964 |
| 2024-09-11 | Schwab Andrew J. Director | Sale | −36,504 | $6.60 | $241K | 1,681,685 |
| 2024-09-11 | Schwab Andrew J. Director | Sale | −1,440 | $6.60 | $10K | 66,356 |
| 2024-09-11 | 5AM Partners VII, LLC 10% owner | Sale | −214,556 | $6.60 | $1.4M | 8,178,964 |
| 2024-09-11 | 5AM Partners VII, LLC 10% owner | Sale | −36,504 | $6.60 | $241K | 1,681,685 |
| 2024-09-11 | 5AM Partners VII, LLC 10% owner | Sale | −1,440 | $6.60 | $10K | 66,356 |
| 2024-09-03 | Arora Puneet S. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +225,000 | 225,000 | ||
| 2024-08-26 | DHILLON PUNIT Chief Executive Officer | Other acquisition | +15,727 | 412,733 | ||
| 2024-07-02 | Smith Karen L. Director | Grant or award · Director Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2024-03-13 | 5AM Partners VII, LLC 10% owner | Purchase | +450,000 | $10.00 | $4.5M | 8,393,520 |
| 2024-03-13 | Schwab Andrew J. Director | Grant or award | +450,000 | $10.00 | $4.5M | 8,393,520 |
| 2024-02-29 | Grayson Paul A. Director | Grant or award | +100,000 | 346,252 | ||
| 2024-02-29 | Grayson Paul A. Director | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 |
Page 7 of 15 · 292 trades